Yarrow Bioscience (YARW) Minority Interest (2022)
Yarrow Bioscience's (YARW) quarterly Minority Interest came in at $211000.0 in Q4 2022.
Analysis
Yarrow Bioscience (YARW) Minority Interest (2022) Analysis & Trends
Yarrow Bioscience (YARW) has reported Minority Interest for 1 consecutive years, with $211000.0 the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Minority Interest changed N/A year-over-year to $211000.0; the trailing twelve-month figure through Dec 2022 stood at $211000.0 (changed N/A YoY), and the FY2022 full-year result was $211000.0, changed N/A from the prior year.
- Minority Interest steadied at $211000.0 in Q4 2022 per YARW's latest filing.
- Across five years, Minority Interest topped out at $211000.0 in Q4 2022 and bottomed at $211000.0 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Yarrow Bioscience | 25.92 Mn | 3.00 Mn | - |